Paul A. LaViolette
DirectoratPulse Biosciences· In proxies 2022–2025
Pay in FY2025Pulse Biosciences stock -21.1% the same year
Paul A. LaViolette was paid $7.4M in FY2025 (Dec). Pulse Biosciences stock fell 21.1% that year.
Pay$100 in the stock at the end of FY21 → $93
Experience
- Edwards LifesciencesPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Pulse BiosciencesPublic company · 4 yr
- Chief Executive Officer and Co-Chairman2022 – Present · 4 yrStock in role +258%
- Asensus Surgical, Inc. (formerly known as TransEnterix, Inc.), from 2014 to 2021Public company
- Director? – PresentNo stock prices for these years
- Directorships Previously Held:Public company
- Director? – PresentNo stock prices for these years
- Misonix, Inc., from 2019 to 2021Public company
- Director? – PresentNo stock prices for these years
- Pulse Biosciences, Inc., since 2024 – Co-Chairman of the Board Other Public CompanyPublic company
- Director? – PresentNo stock prices for these years
- Thoratec Laboratories Corporation, from 2009 to 2015 Select ProfessionalPublic company
- Director? – PresentNo stock prices for these years
- Thoratec CorporationPublic company · 17 yr
- Director2009 – Present · 17 yrNo stock prices for these years
- Misonix, Inc.Public company · 2 yr
- Director2019 – 2021 · 2 yrNo stock prices for these years
- Asensus Surgical, Inc.Public company · 8 yr
- Director2013 – 2021 · 8 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Boards1
- Edwards LifesciencesDirector · 3 yr on the boardIndependentCompensation and Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?